Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Grand Rapids, Michigan Clinical Trials

A listing of Grand Rapids, Michigan clinical trials actively recruiting patient volunteers.

RESULTS

Found (4) clinical trials

Blinatumomab in Combination With Chemotherapy in Treating Patients With or Without Down Syndrome and Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia or Localized B-Lymphoblastic Lymphoma

PRIMARY OBJECTIVES: I. To determine in a randomized manner if the addition of 2 cycles of blinatumomab to standard therapy improves disease-free survival (DFS) in patients with standard risk (SR) B-ALL and higher risk features (SR-High), and patients with standard-risk average (SR-Avg) B-ALL who are negative for minimal residual disease ...

Phase

1.74 miles

Learn More »

Study of CPI-200 in Patients With Advanced Tumors

Primary Objectives: To determine the safety, tolerability and maximum tolerated dose (MTD) of CPI-200 in patients with advanced tumors Secondary Objectives: To evaluate the pharmacokinetics (PK) of CPI-200 To evaluate clinical response and resolution of symptoms after CPI-200 treatment To characterize adverse events of CPI-200 in patients with advanced cancers ...

Phase

5.64 miles

Learn More »

Study of CPI-100 in Patients With Advanced Tumors

Primary Objectives: To determine the safety, tolerability and maximum tolerated dose (MTD) of CPI-100 in patients with advanced tumors Secondary Objectives: To evaluate the pharmacokinetics (PK) of CPI-100 To evaluate clinical response and resolution of symptoms after CPI-100 treatment To characterize adverse events of CPI-100 in patients with advanced cancers ...

Phase

5.64 miles

Learn More »

A Study Evaluating the Safety Tolerability and Initial Efficacy of Recombinant Human Anti-cluster Differentiation Antigen 47 (CD47) Monoclonal Antibody Injection (IBI188) in Patients With Advanced Malignant Tumors and Lymphomas

The study is composed of two stages: Part 1 Accelerated Titration Phase and Part 2 Dose Escalation Phase with initial fixed priming dose. The starting dose for part 1 is 0.1 mg/kg QW, followed by 2 dose cohorts (0.3 mg/kg QW and 1 mg/kg QW). Duration of dose limiting toxicity ...

Phase

5.64 miles

Learn More »